A Feasibility Study to Assess the Visual Performance and Comfort of Hanita G4 Multifocal Soft Contact Lenses for Presbyopia at Normal Daily Routine Use

Sponsor
Hanita Lenses (Industry)
Overall Status
Completed
CT.gov ID
NCT04841941
Collaborator
(none)
25
2
1
31
12.5
0.4

Study Details

Study Description

Brief Summary

The G4 Multi multifocal contact lens is a soft contact lens intended to correct far, intermediate, and near vision for individuals with presbyopia. The lens covers the cornea and part of the sclera. The lenses can be used for daily wear for up to 1 year.

Condition or Disease Intervention/Treatment Phase
  • Device: G4 Multifocal soft contact lens with a 54% water content for presbyopia
N/A

Detailed Description

Study Design:

A clinical performance study without a control group to compare the G4Multi contact lens to other approved soft contact lenses for presbyopia

Study Objectives:
  1. To assess the multifocal vision in the various ranges of the HANITA G4 Multi.

  2. To rate the comfort of the lenses in individuals with presbyopia

Study population:

Healthy men and women above the age of 18 diagnosed with presbyopia who have used contact lenses in the past

Recruitment :

A total of 30 subjects completing at least 1 month of participation.

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Feasibility Study to Assess the Visual Performance and Comfort of Hanita G4 Multifocal Soft Contact Lenses for Presbyopia at Normal Daily Routine Use.
Actual Study Start Date :
Jul 17, 2018
Actual Primary Completion Date :
Feb 16, 2021
Actual Study Completion Date :
Feb 16, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: single arm

G4 Multifocal soft contact lens with a 54% water content for presbyopia

Device: G4 Multifocal soft contact lens with a 54% water content for presbyopia
The participants must agree to wear lenses from a trial set with the fit assessed according to the "Fitting Guide". Prescription lenses will then be ordered from the manufacturer.

Outcome Measures

Primary Outcome Measures

  1. Assess visual acuity [11-12 months]

    Distance (far) manifest refraction and the testing distance used will be recorded on the case report forms. Manifest refraction will be determined using the maximum plus for best visual acuity method. The distance manifest refraction will be measured with a distance adjusted chart but not less than 4 meters. The actual manifest refraction distance will be noted on the case report forms. Results will be recorded in a Log Mar scale.

Secondary Outcome Measures

  1. Assess subjective degree of comfort while wearing the lenses [11-12 months]

    Participants will be asked to fill in a "Subjective Use Questionnaire" (appendix 2) .

  2. SLIT LAMP EXAM [11-12 months]

    The slit lamp exam will include the entire cornea, sclera and conjunctiva exclusion symptoms: See ISO 11980 Annex B (informative) Procedures for the evaluation of safety, physiological performance and effects on ocular tissues.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Presbyopia participants with healthy eyes who are not using any ocular medications, aged 18 years and over and who have used contact lenses in the past

  2. Lens powers within the range available for the test lenses

  3. Best spectacle-corrected visual acuity equal or greater than 20/25 (less than or equal to Log MAR 0.1)

Exclusion Criteria:
  1. Anterior segment infection, inflammation, or abnormality

  2. Any active anterior segment ocular disease that would contraindicate contact lens wear

  3. The use of systemic or ocular medications that would contraindicate contact lens wear

  4. History of herpetic keratitis

  5. History of refractive surgery or irregular cornea

  6. Slit lamp findings that are more serious than grade 1

  7. Corneal vascularization greater than 1 mm of penetration

  8. Pathologically dry eye;

  9. Participation in a contact lens or contact lens care product clinical trial within the previous 30 days

Contacts and Locations

Locations

Site City State Country Postal Code
1 CLC Ra'anana Israel
2 Bar Ilan Ramat Gan Israel

Sponsors and Collaborators

  • Hanita Lenses

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hanita Lenses
ClinicalTrials.gov Identifier:
NCT04841941
Other Study ID Numbers:
  • G4Multi
First Posted:
Apr 12, 2021
Last Update Posted:
Apr 12, 2021
Last Verified:
Apr 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 12, 2021